Comparison of phentermine-amphetamine resin complex with sustained-release dextroamphetamine and placebo in the treatment of exogenous obesity.
D000328:Adult; D000368:Aged; D000661:Amphetamine / Q000009:adverse effects / Q000627:therapeutic use*; D001067:Appetite Depressants / Q000009:adverse effects / Q000627:therapeutic use*; D001069:Appetite Regulation; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D003913:Dextroamphetamine / Q000009:adverse effects / Q000627:therapeutic use*; D004038:Diet, Reducing; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy*; D010627:Phenethylamines / Q000009:adverse effects / Q000627:therapeutic use*; D010645:Phentermine; D010919:Placebos
D001067:Appetite Depressants; D003692:Delayed-Action Preparations; D010627:Phenethylamines; D010919:Placebos; D010645:Phentermine; D000661:Amphetamine; D003913:Dextroamphetamine